Suppr超能文献

心脏手术期间的全身炎症反应:一项初步研究。

Systemic inflammatory response during cardiac surgery: a pilot study.

作者信息

Fitzgerald David C, Holmes Sari D, St Onge John R, Ioanou Chidima, Martin Lisa M, Ad Niv

机构信息

From the Division of Cardiothoracic Surgery, Inova Heart and Vascular Institute, Falls Church, VA USA.

出版信息

Innovations (Phila). 2015 Mar-Apr;10(2):125-32. doi: 10.1097/IMI.0000000000000123.

Abstract

OBJECTIVE

There is a growing body of evidence indicating that perioperative fluid management during cardiac surgery influences patient care and outcome. The choice of fluid therapy and the degree of systemic inflammatory response triggered during surgery control the effects of tissue edema formation and end-organ function. As such, "goal-directed" fluid resuscitation protocols that measure colloid osmotic pressure (COP) may promote improvements in patient morbidity and mortality.

METHODS

Thirty patients scheduled for primary coronary artery bypass grafting were prospectively randomized for perioperative fluid treatment under COP guidance [albumin (ALB), n = 17] or conventional fluid protocols without COP support (control, n = 13). Whole-blood samples were drawn at four different time intervals including (A) anesthesia induction, (B) 10 minutes after the initiation of cardiopulmonary bypass, (C) at the completion of sternal skin approximation, and (D) 3 hours after admission to the cardiac intensive care unit. Interleukin 6 (IL-6) and IL-8 were measured by immunometric, enzyme-linked immunosorbent assays as well as C-reactive protein. Colloid osmotic pressure values were measured using a colloid osmometer.

RESULTS

As compared with conventional fluid protocols, the patients treated in the intervention (ALB) group received significantly less total perioperative fluid [7893.6 (1874.5) vs 10,754.8 (2403.9), P = 0.001], and this relationship remained after controlling for age, sex, and The Society of Thoracic Surgeons risk score (β = -0.5, t = -3.1, P = 0.005). Colloid osmotic pressure values were significantly higher in the ALB group at time point D after surgery (P = 0.03). There were no significant differences in IL-6, IL-8, and C-reactive protein values between the groups at any of the time blood draw intervals. Perioperative outcomes were evaluated by treatment group. For both groups, the incidence of perioperative morbidity was low and did not differ by treatment group.

CONCLUSIONS

The use of COP-guided fluid resuscitation was associated with a significant reduction in perioperative fluid demand. However, patients prescribed to COP-guided fluid therapy did not experience a reduction in whole-body inflammation or improved surgical outcome as compared with conventional fluid management techniques.

摘要

目的

越来越多的证据表明,心脏手术期间的围手术期液体管理会影响患者护理及预后。液体治疗的选择以及手术期间引发的全身炎症反应程度控制着组织水肿形成和终末器官功能的影响。因此,测量胶体渗透压(COP)的“目标导向”液体复苏方案可能会改善患者的发病率和死亡率。

方法

30例计划进行首次冠状动脉搭桥手术的患者被前瞻性随机分为在COP指导下进行围手术期液体治疗组[白蛋白(ALB),n = 17]或无COP支持的传统液体方案组(对照组,n = 13)。在四个不同时间点采集全血样本,包括(A)麻醉诱导时、(B)体外循环开始后10分钟、(C)胸骨皮肤缝合完成时以及(D)进入心脏重症监护病房3小时后。通过免疫测定、酶联免疫吸附测定以及C反应蛋白测量白细胞介素6(IL - 6)和IL - 8。使用胶体渗透压计测量胶体渗透压值。

结果

与传统液体方案相比,干预(ALB)组患者围手术期总液体摄入量显著更少[7893.6(1874.5)对10754.8(2403.9),P = 0.001],在控制年龄、性别和胸外科医师协会风险评分后这种关系仍然存在(β = -0.5,t = -3.1,P = 0.005)。术后时间点D时,ALB组的胶体渗透压值显著更高(P = 0.03)。在任何采血时间间隔,两组之间的IL - 6、IL - 8和C反应蛋白值均无显著差异。按治疗组评估围手术期结局。两组围手术期发病率均较低,且治疗组之间无差异。

结论

使用COP指导的液体复苏与围手术期液体需求显著减少相关。然而,与传统液体管理技术相比,采用COP指导液体治疗的患者并未出现全身炎症减轻或手术结局改善的情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验